Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
7,711
archived clinical trials in
Depression

A Study to Evaluate SAGE-547 in Patients With Moderate Postpartum Depression
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study Evaluating the Efficacy, Safety, and Pharmacokinetics of SAGE-547 Injection in the Treatment of Adult Female Subjects With Severe Postpartum Depression and Adult Female Subjects With Moderate Postpartum Depression
Status: Enrolling
Updated:  12/31/1969
Sage Investigational Site
577
mi
from
Baytown, TX
A Study to Evaluate SAGE-547 in Patients With Moderate Postpartum Depression
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study Evaluating the Efficacy, Safety, and Pharmacokinetics of SAGE-547 Injection in the Treatment of Adult Female Subjects With Severe Postpartum Depression and Adult Female Subjects With Moderate Postpartum Depression
Status: Enrolling
Updated: 12/31/1969
Sage Investigational Site
577
mi
from
Baytown, TX
Click here to add this to my saved trials
A Study to Evaluate SAGE-547 in Patients With Moderate Postpartum Depression
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study Evaluating the Efficacy, Safety, and Pharmacokinetics of SAGE-547 Injection in the Treatment of Adult Female Subjects With Severe Postpartum Depression and Adult Female Subjects With Moderate Postpartum Depression
Status: Enrolling
Updated:  12/31/1969
Sage Investigational Site
569
mi
from
Houston, TX
A Study to Evaluate SAGE-547 in Patients With Moderate Postpartum Depression
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study Evaluating the Efficacy, Safety, and Pharmacokinetics of SAGE-547 Injection in the Treatment of Adult Female Subjects With Severe Postpartum Depression and Adult Female Subjects With Moderate Postpartum Depression
Status: Enrolling
Updated: 12/31/1969
Sage Investigational Site
569
mi
from
Houston, TX
Click here to add this to my saved trials
A Study to Evaluate SAGE-547 in Patients With Moderate Postpartum Depression
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study Evaluating the Efficacy, Safety, and Pharmacokinetics of SAGE-547 Injection in the Treatment of Adult Female Subjects With Severe Postpartum Depression and Adult Female Subjects With Moderate Postpartum Depression
Status: Enrolling
Updated:  12/31/1969
Sage Investigational Site
1153
mi
from
Orange, CA
A Study to Evaluate SAGE-547 in Patients With Moderate Postpartum Depression
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study Evaluating the Efficacy, Safety, and Pharmacokinetics of SAGE-547 Injection in the Treatment of Adult Female Subjects With Severe Postpartum Depression and Adult Female Subjects With Moderate Postpartum Depression
Status: Enrolling
Updated: 12/31/1969
Sage Investigational Site
1153
mi
from
Orange, CA
Click here to add this to my saved trials
A Study to Evaluate SAGE-547 in Patients With Moderate Postpartum Depression
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study Evaluating the Efficacy, Safety, and Pharmacokinetics of SAGE-547 Injection in the Treatment of Adult Female Subjects With Severe Postpartum Depression and Adult Female Subjects With Moderate Postpartum Depression
Status: Enrolling
Updated:  12/31/1969
Sage Investigational Site
721
mi
from
Edgewood, KY
A Study to Evaluate SAGE-547 in Patients With Moderate Postpartum Depression
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study Evaluating the Efficacy, Safety, and Pharmacokinetics of SAGE-547 Injection in the Treatment of Adult Female Subjects With Severe Postpartum Depression and Adult Female Subjects With Moderate Postpartum Depression
Status: Enrolling
Updated: 12/31/1969
Sage Investigational Site
721
mi
from
Edgewood, KY
Click here to add this to my saved trials
A Study to Evaluate SAGE-547 in Patients With Moderate Postpartum Depression
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study Evaluating the Efficacy, Safety, and Pharmacokinetics of SAGE-547 Injection in the Treatment of Adult Female Subjects With Severe Postpartum Depression and Adult Female Subjects With Moderate Postpartum Depression
Status: Enrolling
Updated:  12/31/1969
Sage investigational Site
576
mi
from
San Antonio, TX
A Study to Evaluate SAGE-547 in Patients With Moderate Postpartum Depression
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study Evaluating the Efficacy, Safety, and Pharmacokinetics of SAGE-547 Injection in the Treatment of Adult Female Subjects With Severe Postpartum Depression and Adult Female Subjects With Moderate Postpartum Depression
Status: Enrolling
Updated: 12/31/1969
Sage investigational Site
576
mi
from
San Antonio, TX
Click here to add this to my saved trials
A Study to Evaluate SAGE-547 in Patients With Moderate Postpartum Depression
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study Evaluating the Efficacy, Safety, and Pharmacokinetics of SAGE-547 Injection in the Treatment of Adult Female Subjects With Severe Postpartum Depression and Adult Female Subjects With Moderate Postpartum Depression
Status: Enrolling
Updated:  12/31/1969
Sage Investigational Site
226
mi
from
Rogers, AR
A Study to Evaluate SAGE-547 in Patients With Moderate Postpartum Depression
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study Evaluating the Efficacy, Safety, and Pharmacokinetics of SAGE-547 Injection in the Treatment of Adult Female Subjects With Severe Postpartum Depression and Adult Female Subjects With Moderate Postpartum Depression
Status: Enrolling
Updated: 12/31/1969
Sage Investigational Site
226
mi
from
Rogers, AR
Click here to add this to my saved trials
A Study to Evaluate SAGE-547 in Patients With Moderate Postpartum Depression
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study Evaluating the Efficacy, Safety, and Pharmacokinetics of SAGE-547 Injection in the Treatment of Adult Female Subjects With Severe Postpartum Depression and Adult Female Subjects With Moderate Postpartum Depression
Status: Enrolling
Updated:  12/31/1969
Sage Investigational Site
1165
mi
from
Bellflower, CA
A Study to Evaluate SAGE-547 in Patients With Moderate Postpartum Depression
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study Evaluating the Efficacy, Safety, and Pharmacokinetics of SAGE-547 Injection in the Treatment of Adult Female Subjects With Severe Postpartum Depression and Adult Female Subjects With Moderate Postpartum Depression
Status: Enrolling
Updated: 12/31/1969
Sage Investigational Site
1165
mi
from
Bellflower, CA
Click here to add this to my saved trials
A Study to Evaluate SAGE-547 in Patients With Moderate Postpartum Depression
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study Evaluating the Efficacy, Safety, and Pharmacokinetics of SAGE-547 Injection in the Treatment of Adult Female Subjects With Severe Postpartum Depression and Adult Female Subjects With Moderate Postpartum Depression
Status: Enrolling
Updated:  12/31/1969
Sage Investigational Site
1135
mi
from
Lemon Grove, CA
A Study to Evaluate SAGE-547 in Patients With Moderate Postpartum Depression
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study Evaluating the Efficacy, Safety, and Pharmacokinetics of SAGE-547 Injection in the Treatment of Adult Female Subjects With Severe Postpartum Depression and Adult Female Subjects With Moderate Postpartum Depression
Status: Enrolling
Updated: 12/31/1969
Sage Investigational Site
1135
mi
from
Lemon Grove, CA
Click here to add this to my saved trials
A Study to Evaluate SAGE-547 in Patients With Moderate Postpartum Depression
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study Evaluating the Efficacy, Safety, and Pharmacokinetics of SAGE-547 Injection in the Treatment of Adult Female Subjects With Severe Postpartum Depression and Adult Female Subjects With Moderate Postpartum Depression
Status: Enrolling
Updated:  12/31/1969
Sage Investigational Site
789
mi
from
Pensacola, FL
A Study to Evaluate SAGE-547 in Patients With Moderate Postpartum Depression
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study Evaluating the Efficacy, Safety, and Pharmacokinetics of SAGE-547 Injection in the Treatment of Adult Female Subjects With Severe Postpartum Depression and Adult Female Subjects With Moderate Postpartum Depression
Status: Enrolling
Updated: 12/31/1969
Sage Investigational Site
789
mi
from
Pensacola, FL
Click here to add this to my saved trials
A Study to Evaluate SAGE-547 in Patients With Moderate Postpartum Depression
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study Evaluating the Efficacy, Safety, and Pharmacokinetics of SAGE-547 Injection in the Treatment of Adult Female Subjects With Severe Postpartum Depression and Adult Female Subjects With Moderate Postpartum Depression
Status: Enrolling
Updated:  12/31/1969
Sage Investigational Site
746
mi
from
Dayton, OH
A Study to Evaluate SAGE-547 in Patients With Moderate Postpartum Depression
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study Evaluating the Efficacy, Safety, and Pharmacokinetics of SAGE-547 Injection in the Treatment of Adult Female Subjects With Severe Postpartum Depression and Adult Female Subjects With Moderate Postpartum Depression
Status: Enrolling
Updated: 12/31/1969
Sage Investigational Site
746
mi
from
Dayton, OH
Click here to add this to my saved trials
A Study to Evaluate SAGE-547 in Patients With Moderate Postpartum Depression
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study Evaluating the Efficacy, Safety, and Pharmacokinetics of SAGE-547 Injection in the Treatment of Adult Female Subjects With Severe Postpartum Depression and Adult Female Subjects With Moderate Postpartum Depression
Status: Enrolling
Updated:  12/31/1969
Sage Investigational Site
1196
mi
from
Downingtown, PA
A Study to Evaluate SAGE-547 in Patients With Moderate Postpartum Depression
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study Evaluating the Efficacy, Safety, and Pharmacokinetics of SAGE-547 Injection in the Treatment of Adult Female Subjects With Severe Postpartum Depression and Adult Female Subjects With Moderate Postpartum Depression
Status: Enrolling
Updated: 12/31/1969
Sage Investigational Site
1196
mi
from
Downingtown, PA
Click here to add this to my saved trials
A Study to Evaluate SAGE-547 in Patients With Moderate Postpartum Depression
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study Evaluating the Efficacy, Safety, and Pharmacokinetics of SAGE-547 Injection in the Treatment of Adult Female Subjects With Severe Postpartum Depression and Adult Female Subjects With Moderate Postpartum Depression
Status: Enrolling
Updated:  12/31/1969
Sage Investigational Site
1243
mi
from
Richland, WA
A Study to Evaluate SAGE-547 in Patients With Moderate Postpartum Depression
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study Evaluating the Efficacy, Safety, and Pharmacokinetics of SAGE-547 Injection in the Treatment of Adult Female Subjects With Severe Postpartum Depression and Adult Female Subjects With Moderate Postpartum Depression
Status: Enrolling
Updated: 12/31/1969
Sage Investigational Site
1243
mi
from
Richland, WA
Click here to add this to my saved trials
A Study to Evaluate SAGE-547 in Patients With Moderate Postpartum Depression
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study Evaluating the Efficacy, Safety, and Pharmacokinetics of SAGE-547 Injection in the Treatment of Adult Female Subjects With Severe Postpartum Depression and Adult Female Subjects With Moderate Postpartum Depression
Status: Enrolling
Updated:  12/31/1969
Sage Investigational Site
1234
mi
from
Long Branch, NJ
A Study to Evaluate SAGE-547 in Patients With Moderate Postpartum Depression
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study Evaluating the Efficacy, Safety, and Pharmacokinetics of SAGE-547 Injection in the Treatment of Adult Female Subjects With Severe Postpartum Depression and Adult Female Subjects With Moderate Postpartum Depression
Status: Enrolling
Updated: 12/31/1969
Sage Investigational Site
1234
mi
from
Long Branch, NJ
Click here to add this to my saved trials
A Study to Evaluate SAGE-547 in Patients With Moderate Postpartum Depression
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study Evaluating the Efficacy, Safety, and Pharmacokinetics of SAGE-547 Injection in the Treatment of Adult Female Subjects With Severe Postpartum Depression and Adult Female Subjects With Moderate Postpartum Depression
Status: Enrolling
Updated:  12/31/1969
Sage Investigational Site
887
mi
from
Middleburg Heights, OH
A Study to Evaluate SAGE-547 in Patients With Moderate Postpartum Depression
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study Evaluating the Efficacy, Safety, and Pharmacokinetics of SAGE-547 Injection in the Treatment of Adult Female Subjects With Severe Postpartum Depression and Adult Female Subjects With Moderate Postpartum Depression
Status: Enrolling
Updated: 12/31/1969
Sage Investigational Site
887
mi
from
Middleburg Heights, OH
Click here to add this to my saved trials
A Study to Evaluate SAGE-547 in Patients With Moderate Postpartum Depression
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study Evaluating the Efficacy, Safety, and Pharmacokinetics of SAGE-547 Injection in the Treatment of Adult Female Subjects With Severe Postpartum Depression and Adult Female Subjects With Moderate Postpartum Depression
Status: Enrolling
Updated:  12/31/1969
Sage Investigational Site
337
mi
from
Richardson, TX
A Study to Evaluate SAGE-547 in Patients With Moderate Postpartum Depression
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study Evaluating the Efficacy, Safety, and Pharmacokinetics of SAGE-547 Injection in the Treatment of Adult Female Subjects With Severe Postpartum Depression and Adult Female Subjects With Moderate Postpartum Depression
Status: Enrolling
Updated: 12/31/1969
Sage Investigational Site
337
mi
from
Richardson, TX
Click here to add this to my saved trials
A Study to Evaluate SAGE-547 in Patients With Moderate Postpartum Depression
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study Evaluating the Efficacy, Safety, and Pharmacokinetics of SAGE-547 Injection in the Treatment of Adult Female Subjects With Severe Postpartum Depression and Adult Female Subjects With Moderate Postpartum Depression
Status: Enrolling
Updated:  12/31/1969
Sage Investigational Site
mi
from
Wellington,
A Study to Evaluate SAGE-547 in Patients With Moderate Postpartum Depression
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study Evaluating the Efficacy, Safety, and Pharmacokinetics of SAGE-547 Injection in the Treatment of Adult Female Subjects With Severe Postpartum Depression and Adult Female Subjects With Moderate Postpartum Depression
Status: Enrolling
Updated: 12/31/1969
Sage Investigational Site
mi
from
Wellington,
Click here to add this to my saved trials
A Study to Evaluate SAGE-547 in Patients With Moderate Postpartum Depression
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study Evaluating the Efficacy, Safety, and Pharmacokinetics of SAGE-547 Injection in the Treatment of Adult Female Subjects With Severe Postpartum Depression and Adult Female Subjects With Moderate Postpartum Depression
Status: Enrolling
Updated:  12/31/1969
Sage Investigational Site
mi
from
Neptune, NJ
A Study to Evaluate SAGE-547 in Patients With Moderate Postpartum Depression
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study Evaluating the Efficacy, Safety, and Pharmacokinetics of SAGE-547 Injection in the Treatment of Adult Female Subjects With Severe Postpartum Depression and Adult Female Subjects With Moderate Postpartum Depression
Status: Enrolling
Updated: 12/31/1969
Sage Investigational Site
mi
from
Neptune, NJ
Click here to add this to my saved trials
A Study to Evaluate SAGE-547 in Patients With Moderate Postpartum Depression
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study Evaluating the Efficacy, Safety, and Pharmacokinetics of SAGE-547 Injection in the Treatment of Adult Female Subjects With Severe Postpartum Depression and Adult Female Subjects With Moderate Postpartum Depression
Status: Enrolling
Updated:  12/31/1969
Sage Investigational Site
594
mi
from
Hoffman Estates, IL
A Study to Evaluate SAGE-547 in Patients With Moderate Postpartum Depression
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study Evaluating the Efficacy, Safety, and Pharmacokinetics of SAGE-547 Injection in the Treatment of Adult Female Subjects With Severe Postpartum Depression and Adult Female Subjects With Moderate Postpartum Depression
Status: Enrolling
Updated: 12/31/1969
Sage Investigational Site
594
mi
from
Hoffman Estates, IL
Click here to add this to my saved trials
A Study to Evaluate SAGE-547 in Patients With Moderate Postpartum Depression
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study Evaluating the Efficacy, Safety, and Pharmacokinetics of SAGE-547 Injection in the Treatment of Adult Female Subjects With Severe Postpartum Depression and Adult Female Subjects With Moderate Postpartum Depression
Status: Enrolling
Updated:  12/31/1969
Sage Investigational Site
418
mi
from
Saint Louis, MO
A Study to Evaluate SAGE-547 in Patients With Moderate Postpartum Depression
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study Evaluating the Efficacy, Safety, and Pharmacokinetics of SAGE-547 Injection in the Treatment of Adult Female Subjects With Severe Postpartum Depression and Adult Female Subjects With Moderate Postpartum Depression
Status: Enrolling
Updated: 12/31/1969
Sage Investigational Site
418
mi
from
Saint Louis, MO
Click here to add this to my saved trials
A Study to Evaluate SAGE-547 in Patients With Moderate Postpartum Depression
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study Evaluating the Efficacy, Safety, and Pharmacokinetics of SAGE-547 Injection in the Treatment of Adult Female Subjects With Severe Postpartum Depression and Adult Female Subjects With Moderate Postpartum Depression
Status: Enrolling
Updated:  12/31/1969
Sage Investigational Site
971
mi
from
Pittsburgh, PA
A Study to Evaluate SAGE-547 in Patients With Moderate Postpartum Depression
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study Evaluating the Efficacy, Safety, and Pharmacokinetics of SAGE-547 Injection in the Treatment of Adult Female Subjects With Severe Postpartum Depression and Adult Female Subjects With Moderate Postpartum Depression
Status: Enrolling
Updated: 12/31/1969
Sage Investigational Site
971
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
A Study of Rapastinel as Adjunctive Therapy in the Prevention of Relapse in Patients With Major Depressive Disorder
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in the Prevention of Relapse in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
University of Alabama at Birmingham
676
mi
from
Birmingham, AL
A Study of Rapastinel as Adjunctive Therapy in the Prevention of Relapse in Patients With Major Depressive Disorder
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in the Prevention of Relapse in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
University of Alabama at Birmingham
676
mi
from
Birmingham, AL
Click here to add this to my saved trials
A Study of Rapastinel as Adjunctive Therapy in the Prevention of Relapse in Patients With Major Depressive Disorder
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in the Prevention of Relapse in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Harmonex Neuroscience Research
836
mi
from
Dothan, AL
A Study of Rapastinel as Adjunctive Therapy in the Prevention of Relapse in Patients With Major Depressive Disorder
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in the Prevention of Relapse in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Harmonex Neuroscience Research
836
mi
from
Dothan, AL
Click here to add this to my saved trials
A Study of Rapastinel as Adjunctive Therapy in the Prevention of Relapse in Patients With Major Depressive Disorder
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in the Prevention of Relapse in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
NoesisPharma
844
mi
from
Phoenix, AZ
A Study of Rapastinel as Adjunctive Therapy in the Prevention of Relapse in Patients With Major Depressive Disorder
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in the Prevention of Relapse in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
NoesisPharma
844
mi
from
Phoenix, AZ
Click here to add this to my saved trials
A Study of Rapastinel as Adjunctive Therapy in the Prevention of Relapse in Patients With Major Depressive Disorder
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in the Prevention of Relapse in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
University of Arizona Department of Psychiatry
835
mi
from
Tucson, AZ
A Study of Rapastinel as Adjunctive Therapy in the Prevention of Relapse in Patients With Major Depressive Disorder
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in the Prevention of Relapse in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
University of Arizona Department of Psychiatry
835
mi
from
Tucson, AZ
Click here to add this to my saved trials
A Study of Rapastinel as Adjunctive Therapy in the Prevention of Relapse in Patients With Major Depressive Disorder
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in the Prevention of Relapse in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Woodland International Research Group, Inc.
372
mi
from
Little Rock, AR
A Study of Rapastinel as Adjunctive Therapy in the Prevention of Relapse in Patients With Major Depressive Disorder
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in the Prevention of Relapse in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Woodland International Research Group, Inc.
372
mi
from
Little Rock, AR
Click here to add this to my saved trials
A Study of Rapastinel as Adjunctive Therapy in the Prevention of Relapse in Patients With Major Depressive Disorder
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in the Prevention of Relapse in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Woodland Research Northwest
226
mi
from
Rogers, AR
A Study of Rapastinel as Adjunctive Therapy in the Prevention of Relapse in Patients With Major Depressive Disorder
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in the Prevention of Relapse in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Woodland Research Northwest
226
mi
from
Rogers, AR
Click here to add this to my saved trials
A Study of Rapastinel as Adjunctive Therapy in the Prevention of Relapse in Patients With Major Depressive Disorder
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in the Prevention of Relapse in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
California Pharmaceutical Research Institute, Inc
1158
mi
from
Anaheim, CA
A Study of Rapastinel as Adjunctive Therapy in the Prevention of Relapse in Patients With Major Depressive Disorder
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in the Prevention of Relapse in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
California Pharmaceutical Research Institute, Inc
1158
mi
from
Anaheim, CA
Click here to add this to my saved trials
A Study of Rapastinel as Adjunctive Therapy in the Prevention of Relapse in Patients With Major Depressive Disorder
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in the Prevention of Relapse in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Southern California Research
1177
mi
from
Beverly Hills, CA
A Study of Rapastinel as Adjunctive Therapy in the Prevention of Relapse in Patients With Major Depressive Disorder
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in the Prevention of Relapse in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Southern California Research
1177
mi
from
Beverly Hills, CA
Click here to add this to my saved trials
A Study of Rapastinel as Adjunctive Therapy in the Prevention of Relapse in Patients With Major Depressive Disorder
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in the Prevention of Relapse in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
ATP Clinical Research, Inc.
1158
mi
from
Costa Mesa, CA
A Study of Rapastinel as Adjunctive Therapy in the Prevention of Relapse in Patients With Major Depressive Disorder
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in the Prevention of Relapse in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
ATP Clinical Research, Inc.
1158
mi
from
Costa Mesa, CA
Click here to add this to my saved trials
A Study of Rapastinel as Adjunctive Therapy in the Prevention of Relapse in Patients With Major Depressive Disorder
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in the Prevention of Relapse in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
ProScience Research Group
1178
mi
from
Culver City, CA
A Study of Rapastinel as Adjunctive Therapy in the Prevention of Relapse in Patients With Major Depressive Disorder
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in the Prevention of Relapse in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
ProScience Research Group
1178
mi
from
Culver City, CA
Click here to add this to my saved trials
A Study of Rapastinel as Adjunctive Therapy in the Prevention of Relapse in Patients With Major Depressive Disorder
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in the Prevention of Relapse in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Collaborative Neuroscience Network
1162
mi
from
Garden Grove, CA
A Study of Rapastinel as Adjunctive Therapy in the Prevention of Relapse in Patients With Major Depressive Disorder
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in the Prevention of Relapse in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Collaborative Neuroscience Network
1162
mi
from
Garden Grove, CA
Click here to add this to my saved trials
A Study of Rapastinel as Adjunctive Therapy in the Prevention of Relapse in Patients With Major Depressive Disorder
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in the Prevention of Relapse in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Behavioral Research Specialists, LLC
1167
mi
from
Glendale, CA
A Study of Rapastinel as Adjunctive Therapy in the Prevention of Relapse in Patients With Major Depressive Disorder
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in the Prevention of Relapse in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Behavioral Research Specialists, LLC
1167
mi
from
Glendale, CA
Click here to add this to my saved trials
A Study of Rapastinel as Adjunctive Therapy in the Prevention of Relapse in Patients With Major Depressive Disorder
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in the Prevention of Relapse in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Sun Valley Research Center
1055
mi
from
Imperial, CA
A Study of Rapastinel as Adjunctive Therapy in the Prevention of Relapse in Patients With Major Depressive Disorder
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in the Prevention of Relapse in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Sun Valley Research Center
1055
mi
from
Imperial, CA
Click here to add this to my saved trials
A Study of Rapastinel as Adjunctive Therapy in the Prevention of Relapse in Patients With Major Depressive Disorder
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in the Prevention of Relapse in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Irvine Center for Clinical Research
1150
mi
from
Irvine, CA
A Study of Rapastinel as Adjunctive Therapy in the Prevention of Relapse in Patients With Major Depressive Disorder
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in the Prevention of Relapse in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Irvine Center for Clinical Research
1150
mi
from
Irvine, CA
Click here to add this to my saved trials
A Study of Rapastinel as Adjunctive Therapy in the Prevention of Relapse in Patients With Major Depressive Disorder
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in the Prevention of Relapse in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Synergy Clinical Research Center of Escondido
1135
mi
from
Lemon Grove, CA
A Study of Rapastinel as Adjunctive Therapy in the Prevention of Relapse in Patients With Major Depressive Disorder
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in the Prevention of Relapse in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Synergy Clinical Research Center of Escondido
1135
mi
from
Lemon Grove, CA
Click here to add this to my saved trials
A Study of Rapastinel as Adjunctive Therapy in the Prevention of Relapse in Patients With Major Depressive Disorder
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in the Prevention of Relapse in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Pharmacology Research Institute
1164
mi
from
Los Alamitos, CA
A Study of Rapastinel as Adjunctive Therapy in the Prevention of Relapse in Patients With Major Depressive Disorder
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in the Prevention of Relapse in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Pharmacology Research Institute
1164
mi
from
Los Alamitos, CA
Click here to add this to my saved trials
A Study of Rapastinel as Adjunctive Therapy in the Prevention of Relapse in Patients With Major Depressive Disorder
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in the Prevention of Relapse in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Pacific Research Partners, LLC
1331
mi
from
Oakland, CA
A Study of Rapastinel as Adjunctive Therapy in the Prevention of Relapse in Patients With Major Depressive Disorder
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in the Prevention of Relapse in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Pacific Research Partners, LLC
1331
mi
from
Oakland, CA
Click here to add this to my saved trials
A Study of Rapastinel as Adjunctive Therapy in the Prevention of Relapse in Patients With Major Depressive Disorder
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in the Prevention of Relapse in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Excell Research, Inc.
1136
mi
from
Oceanside, CA
A Study of Rapastinel as Adjunctive Therapy in the Prevention of Relapse in Patients With Major Depressive Disorder
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in the Prevention of Relapse in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Excell Research, Inc.
1136
mi
from
Oceanside, CA
Click here to add this to my saved trials
A Study of Rapastinel as Adjunctive Therapy in the Prevention of Relapse in Patients With Major Depressive Disorder
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in the Prevention of Relapse in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
NRC Research Institute
1154
mi
from
Orange, CA
A Study of Rapastinel as Adjunctive Therapy in the Prevention of Relapse in Patients With Major Depressive Disorder
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in the Prevention of Relapse in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
NRC Research Institute
1154
mi
from
Orange, CA
Click here to add this to my saved trials
A Study of Rapastinel as Adjunctive Therapy in the Prevention of Relapse in Patients With Major Depressive Disorder
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in the Prevention of Relapse in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Asclepes Research Centers
1176
mi
from
Panorama City, CA
A Study of Rapastinel as Adjunctive Therapy in the Prevention of Relapse in Patients With Major Depressive Disorder
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in the Prevention of Relapse in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Asclepes Research Centers
1176
mi
from
Panorama City, CA
Click here to add this to my saved trials
A Study of Rapastinel as Adjunctive Therapy in the Prevention of Relapse in Patients With Major Depressive Disorder
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in the Prevention of Relapse in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Anderson Clinical Research
1109
mi
from
Redlands, CA
A Study of Rapastinel as Adjunctive Therapy in the Prevention of Relapse in Patients With Major Depressive Disorder
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in the Prevention of Relapse in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Anderson Clinical Research
1109
mi
from
Redlands, CA
Click here to add this to my saved trials
A Study of Rapastinel as Adjunctive Therapy in the Prevention of Relapse in Patients With Major Depressive Disorder
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in the Prevention of Relapse in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
CITRIALS
1123
mi
from
Riverside, CA
A Study of Rapastinel as Adjunctive Therapy in the Prevention of Relapse in Patients With Major Depressive Disorder
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in the Prevention of Relapse in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
CITRIALS
1123
mi
from
Riverside, CA
Click here to add this to my saved trials
A Study of Rapastinel as Adjunctive Therapy in the Prevention of Relapse in Patients With Major Depressive Disorder
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in the Prevention of Relapse in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Artemis Institute for Clinical Research
1139
mi
from
San Diego, CA
A Study of Rapastinel as Adjunctive Therapy in the Prevention of Relapse in Patients With Major Depressive Disorder
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in the Prevention of Relapse in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Artemis Institute for Clinical Research
1139
mi
from
San Diego, CA
Click here to add this to my saved trials
A Study of Rapastinel as Adjunctive Therapy in the Prevention of Relapse in Patients With Major Depressive Disorder
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in the Prevention of Relapse in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
PCSD - Feighner Research
1143
mi
from
San Diego, CA
A Study of Rapastinel as Adjunctive Therapy in the Prevention of Relapse in Patients With Major Depressive Disorder
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in the Prevention of Relapse in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
PCSD - Feighner Research
1143
mi
from
San Diego, CA
Click here to add this to my saved trials
A Study of Rapastinel as Adjunctive Therapy in the Prevention of Relapse in Patients With Major Depressive Disorder
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in the Prevention of Relapse in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Artemis Institute for Clinical Research
1131
mi
from
San Marcos, CA
A Study of Rapastinel as Adjunctive Therapy in the Prevention of Relapse in Patients With Major Depressive Disorder
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in the Prevention of Relapse in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Artemis Institute for Clinical Research
1131
mi
from
San Marcos, CA
Click here to add this to my saved trials
A Study of Rapastinel as Adjunctive Therapy in the Prevention of Relapse in Patients With Major Depressive Disorder
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in the Prevention of Relapse in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Thomas M. Shiovitz, M.D., Inc., DBA California Neuroscience Research Medical Group, Inc.
1177
mi
from
Sherman Oaks, CA
A Study of Rapastinel as Adjunctive Therapy in the Prevention of Relapse in Patients With Major Depressive Disorder
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in the Prevention of Relapse in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Thomas M. Shiovitz, M.D., Inc., DBA California Neuroscience Research Medical Group, Inc.
1177
mi
from
Sherman Oaks, CA
Click here to add this to my saved trials
A Study of Rapastinel as Adjunctive Therapy in the Prevention of Relapse in Patients With Major Depressive Disorder
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in the Prevention of Relapse in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Viking Clinical Research
1119
mi
from
Temecula, CA
A Study of Rapastinel as Adjunctive Therapy in the Prevention of Relapse in Patients With Major Depressive Disorder
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in the Prevention of Relapse in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Viking Clinical Research
1119
mi
from
Temecula, CA
Click here to add this to my saved trials
A Study of Rapastinel as Adjunctive Therapy in the Prevention of Relapse in Patients With Major Depressive Disorder
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in the Prevention of Relapse in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Pacific Clinical Research Medical
1136
mi
from
Upland, CA
A Study of Rapastinel as Adjunctive Therapy in the Prevention of Relapse in Patients With Major Depressive Disorder
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in the Prevention of Relapse in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Pacific Clinical Research Medical
1136
mi
from
Upland, CA
Click here to add this to my saved trials
A Study of Rapastinel as Adjunctive Therapy in the Prevention of Relapse in Patients With Major Depressive Disorder
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in the Prevention of Relapse in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
MCB Clinical Research Center
384
mi
from
Colorado Springs, CO
A Study of Rapastinel as Adjunctive Therapy in the Prevention of Relapse in Patients With Major Depressive Disorder
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in the Prevention of Relapse in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
MCB Clinical Research Center
384
mi
from
Colorado Springs, CO
Click here to add this to my saved trials
A Study of Rapastinel as Adjunctive Therapy in the Prevention of Relapse in Patients With Major Depressive Disorder
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in the Prevention of Relapse in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Comprehensive Psychiatric Care
1389
mi
from
Norwich, CT
A Study of Rapastinel as Adjunctive Therapy in the Prevention of Relapse in Patients With Major Depressive Disorder
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in the Prevention of Relapse in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Comprehensive Psychiatric Care
1389
mi
from
Norwich, CT
Click here to add this to my saved trials